Tag: antibody medicines

Mergers and Acquisitions

AbbVie acquires DJS for $255m cash, fortifies immunology pipeline

October 21, 2022

Via: Pharmaphorum

The acquisition of DJS Antibodies, a privately-held UK-based biotechnology company dedicated to discovering and developing antibody medicines that target difficult-to-drug disease-causing proteins – such as G protein-coupled receptors (GPCRs) – will extend AbbVie’s present discovery research capabilities, through DJS’ proprietary […]